Xogene News

Events

Xogene US Summit 2026

October 20 - 21, 2026

Join us for our fourth annual Xogene US Summit in New York City!

PHUSE US Connect 2027

March 15 - 18, 2027

Xogene at PHUSE US Connect 2027: Advancing AI & Transparency

Insights

Xogene Shortlisted for Best Bespoke or Specialized AI Solution in The 2026 A.I. Awards

Xogene's Transcend advances toward finalist consideration in a global AI awards program.

Where Will EMA's AI Guidance Land: What the Regulatory Gaps Reveal

EMA's 2025 AI Observatory report signals where AI regulation in drug development is headed — here's ...

Sanjay Bagani Honored with DIA Community Engagement Award

Xogene's SVP of Clinical Trial Transparency recognized for advancing knowledge and engagement across...

Product Updates

Prime 4.0.1: Expanding Registry Coverage

Prime 4.0.1 adds support for 17 new country registries and a set of updates to how forms and disclosure data are managed across registries, making it easier to keep data consistent as coverage grows.

Xogene Launches Prime 4.0

Built for How You Disclose — Configure Your Plan, Coordinate Work, and Control Every Disclosure

Transcend: Accelerating Transparency with AI

Purpose-built platform combines 16 years of domain expertise with agentic AI to deliver 80% time savings for transparency activities.

Xogene Launches Prime 3.4.1

Xogene launched the latest iteration of Prime, the leading end-to-end platform that provides unified oversight, automated workflows, and effortless compliance for clinical trial transparency.

Regulatory Updates

EMA Pilot Program & Holiday Schedules

Two regulatory updates this week that clinical trial teams should be aware of: an EMA pilot program ...

Updates from Clinical Trial Highlight Issue 28

This week's regulatory updates include enhancements to the HMA-EMA RWD Catalogues and key developmen...

ClinicalTrials.gov PRS & EMA Updates

ClinicalTrials.gov rolled out significant updates this week, featuring redesigned Record pages and S...